The Use of HMG-CoA Reductase Inhibitors to Prevent Accelerated Graft Atherosclerosis in Heart Transplant Patients

Schroeder J.S. . Cardiac transplantation. In: Isselbacher K.J. , Braunwald E. , Wilson J.D. , Martin J.B. , Fauci A.S. , Kasper D.L. , eds. Harrison's principles of internal medicine. 13th ed. New York: McGraw Hill, 1994: 1009–11.

Gao S-Z , Schroeder J.S. , Alderman E.L. , Hunt S.A. , Silverman J.F. , Wielderhold V. . Clinical and laboratory correlates of accelerated coronary artery disease in the cardiac transplant patient. Circulation 1987; 76(suppl V): V-56–61.

Billingman M.E. . Cardiac transplant atherosclerosis. Transplant Proc 1987; 19: 19–25.

Schroeder J.S. , Gao S-Z . Calcium blockers and atherosclerosis: lessons from the Stanford transplant coronary artery disease/diltiazem trial. Can J Cardiol 1995; 11: 710–5.

Sharpies L.D. , Caine N. , Mullins P. , Scott J.P. , Solis E. , English T.A.H. . Risk factor analysis for the major hazards following heart transplantation — rejection, infection, and coronary occlusive disease. Transplantation 1991; 52: 244–52.

Eich D. , Thompson J.A. , Ko D. , Hastillo A. , Lower R. , Katz S. . Hypercholesterolemia in long-term survivors of heart transplantation: an early marker of accelerated coronary artery disease. J Heart Lung Transplant 1991; 10: 45–9.

Gao S-Z , Schroeder J.S. , Hunt S. , Stinson E.B. . Retransplantation for severe accelerated coronary artery disease in heart transplant recipients. Am J Cardiol 1988; 62: 876–81.

Stark R.P. , McGinn A.L. , Wilson R.F. . Chest pain in cardiac-transplant recipients. Evidence of sensory reinnervation after cardiac transplantation. N Engl J Med 1991; 324: 1791–4.

Gao S-Z , Alderman E.L. , Schroeder J.S. , Silverman J.F. , Hunt S.A. . Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol 1988; 12: 334–40.

McKenney J.M. , Hawkins D.W. , eds. Lipid disorders: pathogenesis, lipid metabolism, detection, and evaluation. In: Handbook on the management of lipid disorders. National Pharmacy Cholesterol Council, 1995: 12–57.

Hess M.L. , Hastillo A. , Mohanakumar T. , Cowley M.J. , Vetrovac G. , Szenpetery S. . Accelerated atherosclerosis in cardiac transplantation: role of cytotoxic B-cell antibodies and hyperlipidemia. Circulation 1983; 68 (suppl II): II-94–101.

Petrossian G.A. , Nichols A.B. , Marboe C.C. , Sciacca R. , Rose E.A. , Smith C.R. . Relation between survival and development of coronary artery disease and anti-HLA antibodies after cardiac transplantation. Circulation 1989; 80(suppl III): III-122–5.

Grattan M.T. , Moreno-Cabral C.E. , Starnes V.A. , Oyer P.E. , Stinson E.B. , Shumway N.E. . Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 261: 3651–6.

Stamler J.S. , Vaughan D.E. , Rudd M.A. , Mudge G.H. , Kirshenbaum J. , Young P. . Frequency of hypercholesterolemia after cardiac transplantation. Am J Cardiol 1988; 62: 1268–72.

Keogh A. , Simons L. , Spratt P. , Esmore D. , Chang V. , Hickie J. . Hyperlipidemia after heart transplantation. J Heart Transplant 1988; 7: 171–5.

Kubo S.H. , Peters J.R. , Knutson K.R. , Hertz M.I. , Olivari M.T. , Bolman R.M. . Factors influencing the development of hypercholesterolemia after cardiac transplantation. Am J Cardiol 1992; 70: 520–6.

Hsu I. , Spinier S.A. , Johnson N.E. . Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia. Ann Pharmacother 1995; 29 743–59.

Wenke K. , Meiser B. , Thiery J. , Amdtz N. , von Scheidt W. , Reichart B. . Is reduction of graft vessel disease by maximal treatment of hypercholesterolemia after heart transplantation possible? Transplant Proc 1995; 27: 1954–5.

Kobashigawa J.A. , Katznelson S. , Laks H. , Johnson J.A. , Yeatman L. , Wang X.M. . Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 1995; 333: 621–7.

Kruezer J. , Bader J. , Jahn L. , Hautmann M. , Kubler W. , Von Hodenberg E. . Chemotaxis of the monocyte cell line U937: dependence on cholesterol and early mevalonate pathway products. Atherosclerosis 1991; 90: 203–9.

Cutts J.L. , Scallen T.J. , Watson J. , Banhurst A.D. . Role of mevalonic acid in the regulation of natural kill cell cytotoxicity. J Cell Physiol 1989; 139: 550–7.

Cutts J.L. , Bankhurst A.D. . Reversal of lovastatin-mediated inhibition of natural killer cell cytotoxicity by interleukin 2. J Cell Physiol 1990; 145: 244–52.

Norman D.J. , Illingworth D.R. , Munson J. , Hosenpud J. . Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin (letter). N Engl J Med 1988; 318: 46–7.

East C. , Alivizatos P.A. , Grundy S.M. , Jones P.H. , Farmer J.A. . Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation (letter). N Engl J Med 1988; 318: 47–8.

Corpier C.L. , Jones P.H. , Suki W.N. , Lederer E.D. , Quinones M.A. , Schmidt S.W. . Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients. JAMA 1988: 260: 239–41.

Kobashigawa J.A. , Murphy F.L. , Stevenson L.W. , Moriguchi J.D. , Kawata N. , Kamjoo P. . Low-dose lovastatin safely lowers cholesterol after cardiac transplantation. Circulation 1990; 82(suppl IV): IV-281–3.

Regazzi M.B. , Iacona I. , Campana C. , Raddato V. , Lesi C. , Perani G. . Altered disposition of pravastatin following concomitant drug therapy with cyclosporin A in transplant recipients. Transplant Proc 1993; 25: 2732–4.

Kuo P.C. , Kirshenbaum J.M. , Gordon J. , Laffel G. , Young P. , DiSesa V.J. . Lovastatin therapy for hypercholesterolemia in cardiac transplant recipients. Am J Cardiol 1989; 64: 631–5.

Anguila M. , Alonso-Pulpon L. , Arizon J.M. , Cavero M.A. , Valles F. , Segovia J. . Comparison of the effectiveness of lovastatin therapy for hypercholesterolemia after heart transplantation between patients with and without pretransplant atherosclerotic coronary artery disease. Am J Cardiol 1994; 74: 776–9.

Barbir M. , Rose M. , Kushwaha S. , Akl S. , Mitchell A. , Yacoub M. . Low-dose simvastatin for the treatment of hypercholesterolemia in recipients of cardiac transplantation. Int J Cardiol 1991; 33: 241–6.

Campana C. , Iacona I. , Regazzi M.B. , Gavazzi A. , Perani G. , Raddato V. . Efficacy and pharmacokinetics of simvastatin in heart transplant recipients. Ann Pharmacother 1995; 29: 235–9.

Vanhaecke J. , Van Cleemput J. , Van Lierde J. , Daenen W. , De Geest H. . Safety and efficacy of low dose simvastatin in cardiac transplant recipients treated with cyclosporine. Transplantation 1994; 58: 42–5.